President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a ...

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...

The medication, typically used for weight loss or diabetes treatment, is showing promise curbing cravings for alcohol and ...

Several studies have served up tantalizing hints about the drugs’ potential cancer prevention benefits, but other results ...

WASHINGTON -- GLP-1 receptor agonist use for weight loss early in pregnancy was associated with a lower likelihood that ...

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity ...

On April 30, 2026, the U.S. Food and Drug Administration announced that it is proposing to exclude semaglutide, tirzepatide, and liraglutide from ...

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and ...

Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol ...

While GLP-1 medications first gained visibility for diabetes care and later for weight loss, researchers are now evaluating ...

Stopping GLP-1 therapy may disrupt glycemic control and reduce cardiovascular benefits without clear perioperative safety ...

The boost in GLP-1 usage means more people seeing these side effects, which in turn creates new demand for hair care products ...